Preventing surprise billing: It may be possible to balance the competing goals of consumer protection and market innovation in state and federal oversight of health plan networks, according to a new opinion piece in The New England Journal of Medicine.
Other featured articles
The U.S. should assess the economic value of drugs rather than leave it up to other countries
Why are prescription drugs are often priced lower overseas? Many countries perform detailed assessments of the economic value of drugs and their benefits, and this could work in the U.S., says William Padula
Texas Ruling Over Obamacare is Wrong to Claim That Without the Insurance Mandate, the Healthcare Law Can’t Survive
The Affordable Care Act’s insurance markets are stable, even without a penalty for those who don’t have coverage.
The Trump Administration Side-Stepped Rulemaking Processes on the ACA’s State Innovation Waivers— And it Could Make Their New Section 1332 Guidance Invalid
Claims that the guidance is procedurally invalid open up potential new avenues for litigation surrounding section 1332 in general and could also become relevant to challenges regarding an approved waiver.
Most Hospitals Receive Failing Score in at Least One Quality Dimension of Their Community Health Needs Assessment
Developing clearer guidelines for measuring a hospital's orientation toward population health would be a big step towards fundamentally improving population health and changing the relationship between a hospital and its community.